| 29 Aug, 02:49 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Reg. 34 (1) Annual Report. | bse |
| 29 Aug, 02:47 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Reg. 34 (1) Annual Report. | bse |
| 26 Aug, 07:31 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 22 Aug, 10:13 am | — | … | Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 19 Aug, 06:44 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Allotment | bse |
| 18 Aug, 12:39 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 17 Aug, 08:23 am | — | … | Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 14 Aug, 04:28 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - FCCB Committee Meeting On Wednesday, 19-August-2026 | bse |
| 14 Aug, 12:46 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 13 Aug, 05:34 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 13 Aug, 05:27 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment | bse |
| 13 Aug, 05:22 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 12 Aug, 08:14 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Financial Results For The Quarter Ended 30/06/2026 | bse |
| 10 Aug, 10:31 am | — | … | Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 09 Aug, 06:49 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026 | bse |
| 14 Jul, 12:12 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 18 Jun, 03:30 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Outcome for Board Meeting Scheduled On Thursday, 18 June 2026 Cancelled | bse |
| 15 Jun, 07:21 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday, 18Th June, 2026 | bse |
| 12 Jun, 08:01 pm | fund_raise | 1 | Sudarshan Pharma approved conversion of 9,00,000 promoter-category preferential warrants into 90,00,000 equity shares at issue price Rs.16.983 (incl. premium Rs.15.983), raising balance warrant money of Rs.11.46 crore. | bse |
| 11 Jun, 05:43 pm | procedural | 0 | Sudarshan Pharma Industries postponed the Warrants Committee meeting from 11-Jun-2026 to 12-Jun-2026. | bse |
| 10 Jun, 03:58 pm | m_and_a | 2 | Sudarshan Pharma incorporated Sudarshan Industries Inc. as a wholly-owned US subsidiary on 5 June 2026 and subscribed for 1,00,00,000 shares for ~US$100 (approx. Rs. 0.096 crore). | bse |
| 08 Jun, 07:49 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Meeting Of Warrants Committee Of The Company On Thursday, 11/June/2026 | bse |
| 05 Jun, 09:12 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Intimation As Per Regulation 31 (1) & 31 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 | bse |
| 04 Jun, 06:09 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Reply To The Email Dated 18Th May 2026 Seeking 'Discrepancies In Financial Results' | bse |
| 30 May, 10:25 am | — | … | Sudarshan Pharma Industries Ltd - 543828 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 21 May, 12:48 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By Listed Entities. | bse |
| 21 May, 12:40 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Outcome Of Board Meeting Held Today I.E. Thursday, 21St May 2026 | bse |
| 21 May, 12:35 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Allotment | bse |
| 18 May, 09:02 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Update on board meeting | bse |
| 18 May, 06:10 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday, 22Nd May, 2026 | bse |
| 18 May, 01:19 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Email By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Announcement Dated 15/05/2026 | bse |
| 15 May, 05:34 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 15 May, 04:19 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Outcome for Approval Of Upto U.S. $ 20,000,000 Of 8.00% Senior Unsecured Foreign Currency Convertible Bonds Due 2029 Of Sudarshan Pharma Industries Limited | bse |
| 12 May, 03:25 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting To Be Held On Friday, May 15, 2026 | bse |
| 08 May, 06:43 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | bse |
| 01 May, 12:01 am | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | bse |
| 30 Apr, 11:56 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 30 Apr, 11:52 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Audited Financial Results For The Financial Year Ended 31-03-2026 | bse |
| 27 Apr, 06:58 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Scheduled On Thursday, April 30, 2026 | bse |
| 26 Feb, 05:18 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Updates On GST Inspection, Search And Seizure | bse |
| 22 Feb, 05:19 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - GST Inspection, Search And Seizure | bse |
| 18 Feb, 08:07 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 09 Feb, 07:06 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Clarification On Price Movement - Company Reply | bse |
| 09 Feb, 05:51 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Clarification sought from Sudarshan Pharma Industries Ltd | bse |
| 31 Jan, 11:54 am | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 28 Jan, 08:16 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Financial Results For The Quarter And Nine Months Ended 31-12-2025 | bse |
| 22 Jan, 05:57 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Of The Board Of Directors Scheduled To Be Held On Wednesday, 28/January/2026 | bse |
| 17 Dec, 06:58 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 02 Dec, 06:27 pm | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 19 Oct, 08:47 am | — | … | Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |